The Importance of Long-Term Surveillance of Stage IB Melanomas: Unexpectedly Low Survival Subsequent to Recurrence
Value Health
.
2014 Nov;17(7):A618-9.
doi: 10.1016/j.jval.2014.08.2187.
Epub 2014 Oct 26.
Authors
B Leeneman
1
,
M G Franken
1
,
H M Blommestein
1
,
C W M van Gils
2
,
E van der Meijde
3
,
M W J M Wouters
4
,
P W Plaisier
5
,
W H J Kruit
6
,
S van Ruth
7
,
A J Ten Tije
8
,
M P Hendriks
9
,
V M H Coupe
3
,
C A Uyl-de Groot
1
Affiliations
1
Erasmus University, Rotterdam, The Netherlands.
2
GlaxoSmithKline, Zeist, The Netherlands.
3
VU University Medical Center, Amsterdam, The Netherlands.
4
Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
5
Albert Schweitzer Hospital, Dordrecht, The Netherlands.
6
Erasmus Medical Center, Rotterdam, The Netherlands.
7
Tergooi Hospital, Hilversum, The Netherlands.
8
Amphia Hospital, Breda, The Netherlands.
9
Medical Center Alkmaar, Alkmaar, The Netherlands.
PMID:
27202168
DOI:
10.1016/j.jval.2014.08.2187
No abstract available